company background image
SILVAPHL logo

Silva Pharmaceuticals DSE:SILVAPHL Stock Report

Last Price

৳16.20

Market Cap

৳2.2b

7D

0.6%

1Y

-25.0%

Updated

18 Jun, 2024

Data

Company Financials

Silva Pharmaceuticals Limited

DSE:SILVAPHL Stock Report

Market Cap: ৳2.2b

SILVAPHL Stock Overview

Engages in manufacture and marketing of pharmaceutical products in Bangladesh.

SILVAPHL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Silva Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Silva Pharmaceuticals
Historical stock prices
Current Share Price৳16.20
52 Week High৳21.60
52 Week Low৳13.40
Beta0.043
1 Month Change0%
3 Month Change-1.82%
1 Year Change-25.00%
3 Year Change-17.77%
5 Year Change-23.72%
Change since IPO-41.34%

Recent News & Updates

Recent updates

Shareholder Returns

SILVAPHLBD PharmaceuticalsBD Market
7D0.6%1.1%0.1%
1Y-25.0%-24.1%-26.6%

Return vs Industry: SILVAPHL matched the BD Pharmaceuticals industry which returned -24.1% over the past year.

Return vs Market: SILVAPHL exceeded the BD Market which returned -26.6% over the past year.

Price Volatility

Is SILVAPHL's price volatile compared to industry and market?
SILVAPHL volatility
SILVAPHL Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.3%
10% most volatile stocks in BD Market7.7%
10% least volatile stocks in BD Market3.3%

Stable Share Price: SILVAPHL has not had significant price volatility in the past 3 months.

Volatility Over Time: SILVAPHL's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company

FoundedEmployeesCEOWebsite
2001765Saira Khanwww.silvapharma.com

Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh. The company offers drugs for antibiotics, antifungals, analgesics, anti-diabetics, anti-pyretics, anti-inflammatory, anti-ulcerants, respiratory, cardiovascular, central nervous system, dermatology, gastrointenstinal, antiemetic and anti-spasmodic, antibacterial, allergies, cough, and cold, as well as natural sweetner, vitamins and minerals. It also provides medicine and vaccine for farmers and fisheries; agricultural chemicals and public health insecticides; and herbal and neutraceutical products.

Silva Pharmaceuticals Limited Fundamentals Summary

How do Silva Pharmaceuticals's earnings and revenue compare to its market cap?
SILVAPHL fundamental statistics
Market cap৳2.21b
Earnings (TTM)-৳30.91m
Revenue (TTM)৳611.62m

3.6x

P/S Ratio

-71.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SILVAPHL income statement (TTM)
Revenue৳611.62m
Cost of Revenue৳437.92m
Gross Profit৳173.70m
Other Expenses৳204.61m
Earnings-৳30.91m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.23
Gross Margin28.40%
Net Profit Margin-5.05%
Debt/Equity Ratio1.8%

How did SILVAPHL perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

-44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.